Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 21, 2022 Filed Apr 22, 2022 22:08 UTC |
WHEAT DOUGLAS DDirector
|
Exercise / conversionCommon Stock | 2,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025430 · doc4.xml · nonDerivative · entry 1 WHEAT DOUGLAS D · CIK 0001158599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 17:46 UTC |
Knudson Jeffrey RCFO/CAO
|
PurchaseCommon Stock | 11 | $93.17 | $1,024.82 |
DisclosureSEC source: 0001209191-22-018403 · doc4.xml · nonDerivative · entry 2 Knudson Jeffrey R · CIK 0001752946 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,360 Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 17:46 UTC |
Knudson Jeffrey RCFO/CAO
|
PurchaseCommon Stock | 5,349 | $93.30 | $499,061.70 |
DisclosureSEC source: 0001209191-22-018403 · doc4.xml · nonDerivative · entry 1 Knudson Jeffrey R · CIK 0001752946 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,349 Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 00:32 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 2,090 | $105.74 | $221,002.03 |
DisclosureSEC source: 0001209191-22-014379 · doc4.xml · nonDerivative · entry 9 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,441 F16 · kind: The sale of 2,090 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F17 · price: The price reported in this row represents a weighted average price of $105.7426 per share. These shares were sold in multiple transactions at prices ranging from $105.41 to $105.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F18 · balance_after: The number of shares reflected in this column does not include 101,243 vested Restricted Stock Units that the Reporting Person elected to defer at the time of grant until her separation from service with the Company. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 00:32 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 7,838 | $106.43 | $834,192.07 |
DisclosureSEC source: 0001209191-22-014379 · doc4.xml · nonDerivative · entry 8 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,531 F14 · kind: The sale of 7,838 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F15 · price: The price reported in this row represents a weighted average price of $106.4292 per share. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 00:32 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 10,031 | $107.69 | $1,080,215.32 |
DisclosureSEC source: 0001209191-22-014379 · doc4.xml · nonDerivative · entry 7 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,369 F12 · kind: The sale of 10,031 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F13 · price: The price reported in this row represents a weighted average price of $107.6877 per share. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 00:32 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 2,516 | $108.15 | $272,113.45 |
DisclosureSEC source: 0001209191-22-014379 · doc4.xml · nonDerivative · entry 6 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,400 F10 · kind: The sale of 2,516 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F11 · price: The price reported in this row represents a weighted average price of $108.1532 per share. These shares were sold in multiple transactions at prices ranging from $108.015 to $108.475, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 25, 2022 Filed Mar 30, 2023 22:10 UTC |
Jackson Denise LChief Legal Officer
|
SaleCommon Stock | 4,515 | $109.26 | $493,308.90 |
DisclosureSEC source: 0001209191-23-021671 · doc4.xml · nonDerivative · entry 1 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,002 F1 · date: Filed late due to administrative error. F2 · kind: The sale of 4,515 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in this row represents a weighted average price of $109.26 per share. These shares were sold in multiple transactions at prices ranging from $109.17 to $109.62, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4 · balance_after: Due to the late filing, the amount of securities beneficially owned by the reporting person following the reported transactions in subsequently filed Form 4s have been overstated. Read SEC document |
| February 22, 2022 Filed Mar 2, 2022 00:32 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 100 | $107.10 | $10,710.00 |
DisclosureSEC source: 0001209191-22-014379 · doc4.xml · nonDerivative · entry 5 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,916 F9 · kind: The sale of 100 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 22, 2022 Filed Mar 2, 2022 00:32 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 1,076 | $106.28 | $114,358.68 |
DisclosureSEC source: 0001209191-22-014379 · doc4.xml · nonDerivative · entry 4 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,016 F7 · kind: The sale of 1,076 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The price reported in this row represents a weighted average price of $106.2813 per share. These shares were sold in multiple transactions at prices ranging from $106.05 to $106.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 22, 2022 Filed Mar 2, 2022 00:32 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 311 | $105.12 | $32,693.19 |
DisclosureSEC source: 0001209191-22-014379 · doc4.xml · nonDerivative · entry 3 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,092 F5 · kind: The sale of 311 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in this row represents a weighted average price of $105.1228 per share. These shares were sold in multiple transactions at prices ranging from $104.64 to $105.52, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 22, 2022 Filed Mar 2, 2022 00:32 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 1,013 | $104.35 | $105,705.23 |
DisclosureSEC source: 0001209191-22-014379 · doc4.xml · nonDerivative · entry 2 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,403 F3 · kind: The sale of 1,013 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in this row represents a weighted average price of $104.3487 per share. These shares were sold in multiple transactions at prices ranging from $104.02 to $104.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 22, 2022 Filed Mar 2, 2022 00:32 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 200 | $103.72 | $20,743.00 |
DisclosureSEC source: 0001209191-22-014379 · doc4.xml · nonDerivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,416 F1 · kind: The sale of 200 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in this row represents a weighted average price of $103.715 per share. These shares were sold in multiple transactions at prices ranging from $103.63 to $103.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 23:45 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 3,867 | $96.16 | $371,850.72 |
DisclosureSEC source: 0001209191-22-011924 · doc4.xml · nonDerivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,745 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 23:45 UTC |
Hagan Mark ChristopherChief Information and Digital
|
GrantCommon Stock | 7,798 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011924 · doc4.xml · nonDerivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,612 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2019. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2021 for the one-year period beginning on January 1, 2021 and ended December 31, 2021. As a result, 200% of the target amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 23:36 UTC |
Jackson Denise LChief Legal Officer
|
Tax withholdingCommon Stock | 3,599 | $96.16 | $346,079.84 |
DisclosureSEC source: 0001209191-22-011922 · doc4.xml · nonDerivative · entry 2 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,267 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 23:36 UTC |
Jackson Denise LChief Legal Officer
|
GrantCommon Stock | 8,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011922 · doc4.xml · nonDerivative · entry 1 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,866 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2019. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2021 for the one-year period beginning on January 1, 2021 and ended December 31, 2021. As a result, 200% of the target amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 23:26 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 16,335 | $96.16 | $1,570,773.60 |
DisclosureSEC source: 0001209191-22-011918 · doc4.xml · nonDerivative · entry 2 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,616 F2 · kind: Number of shares withheld for tax purposes. F3 · balance_after: The number of shares reflected in this column does not include 101,243 vested Restricted Stock Units that the Reporting Person elected to defer at the time of grant until her separation from service with the Company. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 23:26 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
GrantCommon Stock | 41,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011918 · doc4.xml · nonDerivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,951 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2019. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2021 for the one-year period beginning on January 1, 2021 and ended December 31, 2021. As a result, 200% of the target amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 24, 2022 Filed Jan 27, 2022 00:29 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 3,373 | $96.15 | $324,326.77 |
DisclosureSEC source: 0001209191-22-005116 · doc4.xml · nonDerivative · entry 5 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,441 F9 · kind: The sale of 3,373 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · price: The price reported in this row represents a weighted average price of $96.1538 per share. These shares were sold in multiple transactions at prices ranging from $96.02 to $96.235, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F11 · balance_after: The number of shares reflected in this column does not include 101,243 vested Restricted Stock Units that the Reporting Person elected to defer at the time of grant until her separation from service with the Company. Read SEC document |
| January 24, 2022 Filed Jan 27, 2022 00:29 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 3,045 | $95.31 | $290,208.60 |
DisclosureSEC source: 0001209191-22-005116 · doc4.xml · nonDerivative · entry 4 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,814 F7 · kind: The sale of 3,045 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The price reported in this row represents a weighted average price of $95.3066 per share. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 24, 2022 Filed Jan 27, 2022 00:29 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 4,585 | $94.71 | $434,245.35 |
DisclosureSEC source: 0001209191-22-005116 · doc4.xml · nonDerivative · entry 3 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,859 F5 · kind: The sale of 4,585 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in this row represents a weighted average price of $94.71 per share. These shares were sold in multiple transactions at prices ranging from $93.99 to $94.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 24, 2022 Filed Jan 27, 2022 00:29 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 3,200 | $93.19 | $298,200.96 |
DisclosureSEC source: 0001209191-22-005116 · doc4.xml · nonDerivative · entry 2 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,444 F3 · kind: The sale of 3,200 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in this row represents a weighted average price of $93.1878 per share. These shares were sold in multiple transactions at prices ranging from $92.74 to $93.635, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 24, 2022 Filed Jan 27, 2022 00:29 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 1,200 | $92.49 | $110,992.80 |
DisclosureSEC source: 0001209191-22-005116 · doc4.xml · nonDerivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,644 F1 · kind: The sale of 1,200 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in this row represents a weighted average price of $92.494 per share. These shares were sold in multiple transactions at prices ranging from $91.63 to $92.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 15, 2022 Filed Jan 20, 2022 01:59 UTC |
Jackson Denise LChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 3,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003903 · doc4.xml · derivative · entry 1 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,553 Underlying: Common Stock · 3,553 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second, and third anniversaries of the grant date. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2022 Filed Jan 20, 2022 01:09 UTC |
Knudson Jeffrey RCFO/CAO
|
GrantRestricted Stock Units · Derivative | 4,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003881 · doc4.xml · derivative · entry 1 Knudson Jeffrey R · CIK 0001752946 · CFO/CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,845 Underlying: Common Stock · 4,845 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2022 Filed Jan 19, 2022 22:57 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 14,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003790 · doc4.xml · derivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,214 Underlying: Common Stock · 14,214 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second, and third anniversaries of the grant date. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2022 Filed Jan 20, 2022 01:04 UTC |
Hagan Mark ChristopherChief Information and Digital
|
GrantRestricted Stock Units · Derivative | 4,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003873 · doc4.xml · derivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,038 Underlying: Common Stock · 4,038 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 02:28 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 295 | $114.92 | $33,901.40 |
DisclosureSEC source: 0001209191-22-003143 · doc4.xml · nonDerivative · entry 9 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,844 F17 · kind: The sale of 295 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F18 · balance_after: The number of shares reflected in this column does not include 101,243 vested Restricted Stock Units that the Reporting Person elected to defer at the time of grant until her separation from service with the Company. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 02:28 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 1,316 | $113.21 | $148,984.89 |
DisclosureSEC source: 0001209191-22-003143 · doc4.xml · nonDerivative · entry 8 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,139 F15 · kind: The sale of 1,316 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F16 · price: The price reported in this row represents a weighted average price of $113.2104 per share. These shares were sold in multiple transactions at prices ranging from $112.97 to $113.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 02:28 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 2,510 | $112.10 | $281,371.00 |
DisclosureSEC source: 0001209191-22-003143 · doc4.xml · nonDerivative · entry 7 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,455 F13 · kind: The sale of 2,510 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F14 · price: The price reported in this row represents a weighted average price of $112.10 per share. These shares were sold in multiple transactions at prices ranging from $111.64 to $112.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 02:28 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 1,200 | $111.02 | $133,222.56 |
DisclosureSEC source: 0001209191-22-003143 · doc4.xml · nonDerivative · entry 6 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,965 F11 · kind: The sale of 1,200 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F12 · price: The price reported in this row represents a weighted average price of $111.01875 per share. These shares were sold in multiple transactions at prices ranging from $110.61 to $111.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 02:28 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 1,900 | $109.90 | $208,807.15 |
DisclosureSEC source: 0001209191-22-003143 · doc4.xml · nonDerivative · entry 5 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,165 F9 · kind: The sale of 1,900 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · price: The price reported in this row represents a weighted average price of $109.8985 per share. These shares were sold in multiple transactions at prices ranging from $109.60 to $110.275, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 02:28 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 2,100 | $108.92 | $228,723.81 |
DisclosureSEC source: 0001209191-22-003143 · doc4.xml · nonDerivative · entry 4 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,065 F7 · kind: The sale of 2,100 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The price reported in this row represents a weighted average price of $108.91607 per share. These shares were sold in multiple transactions at prices ranging from $108.42 to $109.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 02:28 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 2,000 | $107.65 | $215,292.60 |
DisclosureSEC source: 0001209191-22-003143 · doc4.xml · nonDerivative · entry 3 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,165 F5 · kind: The sale of 2,000 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in this row represents a weighted average price of $107.64625 per share. These shares were sold in multiple transactions at prices ranging from $107.26 to $108.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 02:28 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 1,400 | $106.58 | $149,217.32 |
DisclosureSEC source: 0001209191-22-003143 · doc4.xml · nonDerivative · entry 2 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,165 F3 · kind: The sale of 1,400 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in this row represents a weighted average price of $106.5838 per share. These shares were sold in multiple transactions at prices ranging from $106.09 to $106.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 02:28 UTC |
SALKA SUSAN RDirector · Chief Executive Officer
|
SaleCommon Stock | 1,588 | $105.06 | $166,840.52 |
DisclosureSEC source: 0001209191-22-003143 · doc4.xml · nonDerivative · entry 1 SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,565 F1 · kind: The sale of 1,588 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in this row represents a weighted average price of $105.0633 per share. These shares were sold in multiple transactions at prices ranging from $104.82 to $105.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 02:45 UTC |
Jackson Denise LChief Legal Officer
|
SaleCommon Stock | 796 | $118.49 | $94,315.25 |
DisclosureSEC source: 0001209191-22-002782 · doc4.xml · nonDerivative · entry 1 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,752 F1 · kind: The sale of 796 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in this row represents a weighted average price of $118.4865 per share. These shares were sold in multiple transactions at prices ranging from $118.225 to $118.545, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2022 Filed Jan 8, 2022 01:52 UTC |
Jackson Denise LChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002611 · doc4.xml · derivative · entry 5 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,259 Underlying: Common Stock · 1,221 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F8 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 6, 2020 and vest on the first, second and third anniversaries of the grant date. F9 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 06, 2022 Filed Jan 8, 2022 01:52 UTC |
Jackson Denise LChief Legal Officer
|
Tax withholdingCommon Stock | 425 | $118.61 | $50,409.25 |
DisclosureSEC source: 0001209191-22-002611 · doc4.xml · nonDerivative · entry 4 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,548 F6 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 06, 2022 Filed Jan 8, 2022 01:52 UTC |
Jackson Denise LChief Legal Officer
|
Exercise / conversionCommon Stock | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002611 · doc4.xml · nonDerivative · entry 3 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:40 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 1,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002730 · doc4.xml · derivative · entry 3 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,203 Underlying: Common Stock · 1,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 6, 2020 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:40 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 541 | $118.61 | $64,168.01 |
DisclosureSEC source: 0001209191-22-002730 · doc4.xml · nonDerivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,814 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:40 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionCommon Stock | 1,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002730 · doc4.xml · nonDerivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 05, 2022 Filed Jan 8, 2022 01:52 UTC |
Jackson Denise LChief Legal Officer
|
SaleCommon Stock | 1,000 | $120.27 | $120,265.00 |
DisclosureSEC source: 0001209191-22-002611 · doc4.xml · nonDerivative · entry 2 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,752 F3 · kind: The sale of 1,000 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in this row represents a weighted average price of $120.265 per share. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 05, 2022 Filed Jan 8, 2022 01:52 UTC |
Jackson Denise LChief Legal Officer
|
SaleCommon Stock | 4,232 | $119.69 | $506,531.89 |
DisclosureSEC source: 0001209191-22-002611 · doc4.xml · nonDerivative · entry 1 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,752 F1 · kind: The sale of 4,232 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in this row represents a weighted average price of $119.6909 per share. These shares were sold in multiple transactions at prices ranging from $119.03 to $119.9875, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 01:28 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 2,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002036 · doc4.xml · derivative · entry 8 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,639 Underlying: Common Stock · 2,284 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 4, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 01:28 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 1,524 | $120.80 | $184,099.20 |
DisclosureSEC source: 0001209191-22-002036 · doc4.xml · nonDerivative · entry 6 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,189 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 01:28 UTC |
Hagan Mark ChristopherChief Information and Digital
|
GrantCommon Stock | 4,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002036 · doc4.xml · nonDerivative · entry 5 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,713 F3 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2019. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2018 for the 3-year period beginning on January 1, 2019 and ended December 31, 2021 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2022. The Company's Relative TSR measured in the 78th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 01:28 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 787 | $120.80 | $95,069.60 |
DisclosureSEC source: 0001209191-22-002036 · doc4.xml · nonDerivative · entry 4 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,306 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.